Alison Lawton

Alison Lawton

Fortune : - $ au 31/05/2026

63 ans
Health Technology
Commercial Services
Consumer Services

Profil

Alison Francis Lawton is currently Director at AgBiome INC since 2021, Director at SwanBio Therapeutics, Inc. since 2021, Independent Director at Dianthus Therapeutics, Inc. since 2023, Director at Bluerock Therapeutics, Inc., and President at Cadena Bio, Inc. Former roles include Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC from 2012 to 2014, Director at CoLucid Pharmaceuticals, Inc. from 2016 to 2017, Independent Director at Spyre Therapeutics, Inc. from 2020 to 2024, Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc. from 2012 to 2020, Director at Kaleido Biosciences, Inc. in 2020, Director at Magenta Therapeutics, Inc. from 2017 to 2018, Independent Director at Magenta Therapeutics, Inc. from 2020 to 2021, Independent Director at X4 Pharmaceuticals, Inc. from 2020 to 2025, Senior Vice President at Genzyme Corp.
from 2011 to 2012, Chief Operating Officer at Aura Biosciences, Inc. from 2015 to 2017, Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp.
from 2012 to 2013, General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc. from 2013 to 2014, Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., Chief Operating Officer at X4 Pharmaceuticals, Inc. from 2014 to 2017, Senior Vice President & General Manager at BIOSURGERY S.R.L., and Independent Member-Supervisory Board at ProQR Therapeutics NV from 2014 to 2026.
Education includes undergraduate studies at King's College London.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/03/2026 0 ( -.--% ) - $ 31/05/2026
21/05/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Alison Lawton

SociétésPosteDébut
DIANTHUS THERAPEUTICS, INC. Président 11/09/2023
President -
Directeur/Membre du Conseil 04/05/2021
Directeur/Membre du Conseil 19/01/2021
Directeur/Membre du Conseil -

Anciens postes connus de Alison Lawton

SociétésPosteFin
PROQR THERAPEUTICS N.V. Directeur/Membre du Conseil 02/06/2026
X4 PHARMACEUTICALS, INC. Directeur/Membre du Conseil 09/06/2025
SPYRE THERAPEUTICS, INC. Directeur/Membre du Conseil 01/02/2024
KALEIDO BIOSCIENCES, INC. Directeur Général 16/06/2020
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Alison Lawton

Formation de Alison Lawton

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

90

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

  1. Bourse
  2. Insiders
  3. Alison Lawton
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇